Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.62 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.62 |
| ▸ | RECQL | P46063 | 4/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.62 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.62 |
| ▸ | DRD2 | P14416 | 3/20 | 0.62 |
| ▸ | DRD1 | P21728 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | APEX1 | P27695 | 3/20 | 0.62 |
| ▸ | DRD4 | P21917 | 2/20 | 0.62 |
| ▸ | DRD5 | P21918 | 2/20 | 0.62 |
| ▸ | DRD3 | P35462 | 2/20 | 0.62 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | HTR1A | P08908 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17138365 | 1.00 | TDP1 (0.62) | TDP1TAAR1KDM4ERECQLMAPK1 | |
| Hydrochloric Acid SCHEMBL3757551 | 0.97 | TDP1 (0.64) | TDP1TAAR1KDM4ERECQLMAPK1 | |
| Water SCHEMBL17686500 | 0.97 | TDP1 (0.60) | TDP1TAAR1KDM4ERECQLMAPK1 | |
| Hydrochloric Acid SCHEMBL29134173 | 0.95 | TDP1 (0.58) | TDP1TAAR1KDM4ERECQLMAPK1 | |
| SCHEMBL69532 | 0.85 | TDP1 (0.54) | TDP1TAAR1KDM4ERECQLMAPK1 | |
| SCHEMBL20849682 | 0.84 | MAPK1 (0.46) | TDP1TAAR1KDM4ERECQLMAPK1 | |
| SCHEMBL28735818 | 0.84 | TAAR1 (0.52) | TDP1TAAR1KDM4ERECQLMAPK1 | |
| SCHEMBL29705208 | 0.84 | TAAR1 (0.52) | TDP1TAAR1KDM4ERECQLMAPK1 | |
| SCHEMBL10634508 | 0.84 | MAPK1 (0.52) | TDP1TAAR1KDM4ERECQLMAPK1 | |
| SCHEMBL5495349 | 0.84 | TAAR1 (0.52) | TDP1TAAR1KDM4ERECQLMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 528 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144903-A1 | RADIONUCLIDE-LABELED BORON-CONTAINING DRUG, AND PREPARATION AND USE THEREOF | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2026-05-28 | — | — | US | claimed |
| EP-4667020-A1 | RADIONUCLIDE-LABELED BORON-CONTAINING DRUG, AND PREPARATION AND USE THEREOF | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2025-12-24 | — | — | EP | claimed |
| EP-4667016-A1 | BORON-CONTAINING DRUG AND PREPARATION METHOD THEREFOR | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2025-12-24 | — | — | EP | claimed |
| EP-4088757-B1 | PHENOL DERIVATIVE-FUNCTIONALIZED CHONDROITIN SULFATE HYDROGEL AND USE OF SAME | CELLARTGEN INC (KR) | 2025-12-10 | — | — | EP | claimed |
| US-12435280-B2 | Crude oil demulsifier compositions and uses thereof | ECOLAB USA INC. (US) | 2025-10-07 | — | — | US | claimed |
| US-20250114479-A1 | TISSUE-SELECTIVE SINGLE-COMPONENT MRNA DELIVERY CARRIER AND DELIVERY SYSTEM | INSTITUTE OF PROCESS ENGINEERING , CHINESE ACADEMY OF SCIENCES (CN) | 2025-04-10 | — | — | US | claimed |
| CN-116516690-B | Fiber impregnating solution for improving bonding effect between nylon fiber and rubber and preparation method thereof | 青岛科技大学 | 2025-03-28 | — | — | CN | claimed |
| US-20250051976-A1 | FIBER COMPOSITE STRUCTURE AND MANUFACTURING METHOD THEREOF | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-02-13 | — | — | US | claimed |
| CN-119386268-A | In-situ gel forming solution containing polydeoxyribonucleotide as well as preparation method and application thereof | 四川兴泰普乐医疗科技有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-117945939-B | Bio-based self-assembled amide nucleating agent, and preparation method and application thereof | 广东工业大学 | 2025-01-28 | — | — | CN | claimed |
| EP-1244435-A2 | POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND $g(a)-SYNUCLEIN FIBRIL DISEASES | Proteotech Inc. (US) | 2002-10-02 | — | — | EP | claimed |
| US-20010047032-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | PROTAMED, INC. | 2001-11-29 | — | — | US | claimed |
| WO-2001049281-A2 | POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND α-SYNUCLEIN FIBRIL DISEASES | PROTEOTECH, INC. (US) | 2001-07-12 | — | — | WO | claimed |
| EP-0672148-A1 | METHOD FOR MAKING STABLE, EXTRACELLULAR TYROSINASE AND SYNTHESIS OF POLYPHENOLIC POLYMERS THEREFROM | Biosource Technologies, Inc. (US) | 1995-09-20 | — | — | EP | claimed |
| US-5340734-A | In vitro biosynthesis the melanins in presence of a substrate consisting of tyrosine binding single amino acid, a dipeptide or an oligopeptide | BIOSOURCE GENETICS CORPORATION (US) | 1994-08-23 | — | — | US | claimed |
| WO-1994012644-A2 | METHOD FOR MAKING STABLE, EXTRACELLULAR TYROSINASE AND SYNTHESIS OF POLYPHENOLIC POLYMERS THEREFROM | BIOSOURCE GENETICS CORPORATION (US) | 1994-06-09 | — | — | WO | claimed |
| US-5258427-A | MIXTURE OF A LIQUID EPOXY RESIN, A METAL OXIDE AND A POLYHYDROXYARYL COMPOUND | ICI AUSTRALIA OPERATIONS PROPRIETARY LTD. (AU) | 1993-11-02 | — | — | US | claimed |
| EP-0458521-A2 | Heat curable adhesive | ICI AUSTRALIA OPERATIONS PROPRIETARY LIMITED (AU) | 1991-11-27 | — | — | EP | claimed |
| EP-0394983-A2 | Anthracycline derivatives with cytostatic activity | BEHRINGWERKE Aktiengesellschaft (DE) | 1990-10-31 | — | — | EP | claimed |
| EP-0394982-A2 | Anthracycline derivatives with cytostatic activity | BEHRINGWERKE Aktiengesellschaft (DE) | 1990-10-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250114479-A1 | TISSUE-SELECTIVE SINGLE-COMPONENT MRNA DELIVERY CARRIER AND DELIVERY SYSTEM | SLC43A1, LNPEP, TLR3 | TDP1 3879/4885TAAR1 1457/4885KDM4E 1745/4885 |
| US-20260144903-A1 | RADIONUCLIDE-LABELED BORON-CONTAINING DRUG, AND PREPARATION AND USE THEREOF | DBH, SLC39A11, GHRHR | TDP1 3270/4885TAAR1 1206/4885KDM4E 3414/4885 |
| US-20010047032-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | SNCA, PARK7, HTT | TDP1 202/4885TAAR1 536/4885KDM4E 2675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.